Literature DB >> 26034092

Added value of pulmonary venous flow Doppler assessment in patients with preserved ejection fraction and its contribution to the diastolic grading paradigm.

Eric Buffle1, Judith Kramarz1, Esther Elazar1, Galit Aviram2, Meirav Ingbir1, Nahum Nesher3, Simon Biner1, Gad Keren1, Yan Topilsky4.   

Abstract

AIMS: To evaluate the prognostic role of pulmonary venous flow parameters and their role in patients with preserved ejection fraction (EF). METHODS AND
RESULTS: Pulmonary venous flow parameters were measured in 365 patients in sinus rhythm, without significant mitral disease, and EF >50% (age 64.9 ± 19; 52% female) by a single sonographer. Survival, time to re-admission for heart failure, and to a combined cardiac end point (cardiac death, heart failure, and atrial fibrillation) were retrospectively analysed and correlated to echo parameters. Systolic (S) and diastolic (D) pulmonary vein flow were obtainable in 73% of patients and Ar in 65%. The lower peak S/D ratio and higher ΔAr-A time were associated with higher rate of heart failure readmission (P = 0.03 for both). The S/D integral ratio was the best pulmonary vein flow predictor of heart failure readmissions (P = 0.0009), better than the peak S/D ratio, or ΔA-Ar time (P < 0.01 for both), and independently predicted worse outcome even when adjusted for diastolic grading (using recent guidelines), left ventricle mass index, E/e', and left atrial volume index (P < 0.05 for all). The addition S/D ratio to diastolic grading recognized patients with pseudo-normal filling pattern and S/D ratio >1 with similar clinical outcomes to grade I (P > 0.5), but worse clinical outcomes than in the pseudo-normal patients with lower S/D ratio (P < 0.01).
CONCLUSIONS: PVFP are obtainable in most patients, add prognostic information on top of routine diastolic parameters, and define an early stage of diastolic dysfunction resembling the pseudo-normal pattern in which S/D ratio is >1, and outcome is excellent. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  difference from mitral A-wave duration; ejection fraction; left atrium; left ventricle; pulmonary venous flow parameters; systolic to diastolic ratio

Mesh:

Year:  2015        PMID: 26034092     DOI: 10.1093/ehjci/jev126

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  5 in total

Review 1.  The Role of Echocardiography in Heart Failure with Preserved Ejection Fraction: What Do We Want from Imaging?

Authors:  Masaru Obokata; Yogesh N V Reddy; Barry A Borlaug
Journal:  Heart Fail Clin       Date:  2019-02-02       Impact factor: 3.179

2.  Pulmonary veins: an important side window into ventricular function.

Authors:  Otto A Smiseth
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-06-23       Impact factor: 6.875

3.  Impact of obesity and epicardial fat on early left atrial dysfunction assessed by cardiac MRI strain analysis.

Authors:  Morgane Evin; Kathryn M Broadhouse; Fraser M Callaghan; Rachel T McGrath; Sarah Glastras; Rebecca Kozor; Samantha L Hocking; Jérôme Lamy; Alban Redheuil; Nadjia Kachenoura; Greg R Fulcher; Gemma A Figtree; Stuart M Grieve
Journal:  Cardiovasc Diabetol       Date:  2016-12-22       Impact factor: 9.951

4.  To determine the correlation between echocardiographic diastolic parameters and invasively measured left ventricular end diastolic pressure in patients with heart failure with preserved ejection fraction- an observational, descriptive study. (CEAL-HFpEF study).

Authors:  Awadhesh Kumar Sharma; Hitender Kumar; M M Razi; Santosh Kumar Sinha; Umeshwar Pandey; Praveen Shukla; Ramesh Thakur; C M Verma; R K Bansal; Vinay Krishna
Journal:  Indian Heart J       Date:  2021-07-06

5.  Predictors of Exercise Capacity in Dilated Cardiomyopathy with Focus on Pulmonary Venous Flow Recorded with Transesophageal Eco-Doppler.

Authors:  Carlo Caiati; Adriana Argentiero; Cinzia Forleo; Stefano Favale; Mario Erminio Lepera
Journal:  J Clin Med       Date:  2021-12-18       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.